The Affect Of An Anti-Embolism Stocking Protocol

Çukurova University

Status: Completed

Conditions: Venous Thromboembolism

Treatments: Other: Anti-Embolism Stocking

Study type: Interventional

Funder types: Other

Identifiers

NCT06616376

CukurovaUBasibüyükErden

Details and patient eligibility

About

This study was conducted to determine the effect of anti-embolism stocking (AES) use protocol affected the development of early venous thromboembolism (VTE) in patients undergoing total knee arthroplasty (TKA).

The randomized controlled single-blind intervention study included 40 patients (Experimental Group: 20, Control Group: 20) who underwent TKA surgery in a university hospital's Orthopedics and Traumatology clinic between 2019 and 2021. While the experimental group received the AES protocol one day before the operation and continued until the 10 th day after the operation, the control group received AES on the 0 th day after the operation and remained in the patient until the 21st day after the operation. In the study, a "Data Collection Form" with DVT and PE signs and symptoms was used.

Full description

The study was carried out at a university hospital's Orthopedics and Traumatology clinic. Knee arthroplasty surgery is performed on an average of 85 patients per year in the hospital with a bed capacity of 1200. The Orthopedics and Traumatology clinic has 36 beds and 9 nurses on staff.

In the clinic, LMWH is given to patients who will have knee arthroplasty 12 hours before the procedure. Following knee arthroplasty, an elastic bandage is placed over the dressing on the operated extremity, and AES is only applied to the intact extremity. AES is dressed on both extremities after the elastic bandage is removed. Foot movements begin on the first postoperative day, and patients are mobilized on the first or second postoperative day. Patients are admitted to the clinic for a period of 5-7 days. LMWH application, which began in the preoperative period, continues in the postoperative period for approximately 21 days (until the sutures are removed). The AES usage protocol is not implemented in the clinic, and no training is provided to patients regarding the use of AES by healthcare personnel. After TKA surgery, AES patients are dressed, and it is recommended that they wear them without removing them for 21 days (sutures are removed).

Enrollment: 40 patients

Sex: All

Ages: 18 to 80 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Older than 18 years old,
• No harm in wearing AES,
• Patients who agreed to participate in the study.

Exclusion criteria

• Bilateral TKA used patients,
• Having excess leg edema, pulmonary edema, heart failure,
• Having leg ischemia,
• Having skin graft,
• An open wound in the area where AES will be applied,
• Having arterial and venous vessel disease,
• Having neuropathy,
• Having cellulite on the patient's leg to whom AES will be applied,
• Having an infection such as fasciitis or panniculitis,
• Those who declare that they will not use AES for ten days in accordance with the recommendations.

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

40 participants in 2 patient groups

Experimental Group

Experimental group

Description:

AES was redressed within the 21st day after the operation

Treatment:

Other: Anti-Embolism Stocking

Control Group

No Intervention group

Description:

The AES was dressed within the 10st day after the operation remained in the patient until the sutures